President Vows to Protect Antibiotics

A new national strategy to combat antibiotic resistance aims to improve diagnostic testing, disease surveillance, and the prevention of inappropriate antibiotic use.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, SAGE ROSSPresident Obama yesterday (September 18) signed an executive order and announced a National Strategy to fight antibiotic resistance. His administration also offered up a $20 million reward for developing a fast diagnostic test that could identify highly resistant bugs.

The National Strategy is a five-year plan including goals such as slowing the spread of drug-resistant bacteria; accelerating the development of new antibiotics, vaccines, and drugs; and enhancing the surveillance of antibiotic resistance. The President's Council of Advisers on Science and Technology (PCAST) also released its report outlining similar strategies.

“What’s new here is there is a highly federal focus that’s highly coordinated,” Eric Lander, the cochair of PCAST and founding director of the Broad Institute of MIT and Harvard, told CNN. “We are endorsing a variety of specific goals in order to get our arms around this problem. If we’re producing antibiotics at a greater rate than we’re losing them, then we win in the long run.”

Those in the infectious disease community appeared ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo